Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DDX27 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIMM17A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PLAUR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LIG3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CLCA3P - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
YIPF5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DYNLT3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AIMP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC101926997 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors
GRIK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GCC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FUT9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BHLHE40 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CRBN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HDAC6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COPA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CREBL2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FGFR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on